CHARTS The story of markets and the economy in 2024 NasdaqGS - Nasdaq Real Time Price • USD Materialise NV (MTLS) Follow Compare 7.07 -0.12 (-1.67%) As of 12:55:54 PM EST. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Three Undiscovered Gems with Strong Financial Foundations Over the last 7 days, the United States market has remained flat, yet it has shown a robust 32% rise over the past 12 months with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying stocks with strong financial foundations can be key to uncovering potential opportunities amidst market fluctuations. Materialise (NASDAQ:MTLS) Is Looking To Continue Growing Its Returns On Capital If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for... Shareholders Will Be Pleased With The Quality of Materialise's (NASDAQ:MTLS) Earnings Materialise NV's ( NASDAQ:MTLS ) strong earnings report was rewarded with a positive stock price move. Our analysis... Results: Materialise NV Beat Earnings Expectations And Analysts Now Have New Forecasts Materialise NV ( NASDAQ:MTLS ) investors will be delighted, with the company turning in some strong numbers with its... Materialise NV (MTLS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Driven by Medical ... Materialise NV (MTLS) reports a 14% revenue increase, with the Medical segment leading growth and strategic advancements in software partnerships. Materialise NV Shows Strong Q3 Revenue Growth Materialise (MTLS) has released an update. Materialise NV reported a 14.2% increase in total revenue for Q3 2024, reaching 68,652 kEUR, with notable growth in their Medical segment. Despite a decline in net profit compared to the previous year, the company achieved an 89% rise in Adjusted EBIT, indicating strong operational performance. Materialise continues to invest in future growth, maintaining confidence in meeting its full-year revenue and EBIT guidance. For further insights into MTLS stock Materialise Shows Revenue Growth Amid Currency Challenges Materialise (MTLS) has released an update. Materialise reported a 14.2% increase in revenue for Q3 2024, driven by strong growth in its Medical segment, despite a decline in net profit due to unfavorable currency exchange effects. The company’s operating result improved significantly, reflecting robust performance across its business units. Materialise’s cash position remains stable, and its adjusted EBITDA saw notable growth, highlighting its potential for sustained financial health. For furthe Discovering Unique Opportunities in Three Undiscovered US Stocks The United States market has remained flat over the past week but has experienced a remarkable 40% increase over the past year, with earnings projected to grow by 15% annually. In such an environment, identifying unique opportunities often involves uncovering stocks that possess strong growth potential and resilience, making them stand out even when broader market movements stabilize. Materialise: Q3 Earnings Snapshot LEVUEN, Belgium (AP) — Materialise NV (MTLS) on Thursday reported net income of $3.4 million in its third quarter. The Levuen, Belgium-based company said it had profit of 6 cents per share. The 3D printing software and medical and industrial products company posted revenue of $76.9 million in the period. Materialise Reports Third Quarter 2024 Results LEUVEN, Belgium, October 24, 2024--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the third quarter ended September 30, 2024. Materialise (NASDAQ:MTLS) investors are sitting on a loss of 77% if they invested three years ago As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses... Materialise NV to Report Third Quarter 2024 Earnings on Thursday, October 24, 2024 LEUVEN, Belgium, October 14, 2024--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the third quarter ended September 30, 2024 on Thursday, October 24, 2024 at 6:30 a.m. ET/12:30 p.m. CET. Materialise NV (MTLS) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... Materialise NV (MTLS) reports a 6.2% revenue increase and strategic advancements in the medical segment amid challenges in prototyping demand. Is Materialise NV's (NASDAQ:MTLS) Recent Stock Performance Influenced By Its Financials In Any Way? Materialise's (NASDAQ:MTLS) stock is up by 6.6% over the past three months. Given that stock prices are usually aligned... Materialise NV's (NASDAQ:MTLS) top owners are private companies with 56% stake, while 28% is held by individual investors Key Insights The considerable ownership by private companies in Materialise indicates that they collectively have a... Is Materialise NV (NASDAQ:MTLS) Potentially Undervalued? Materialise NV ( NASDAQ:MTLS ), is not the largest company out there, but it saw a double-digit share price rise of... Solid Earnings Reflect Materialise's (NASDAQ:MTLS) Strength As A Business Materialise NV's ( NASDAQ:MTLS ) strong earnings report was rewarded with a positive stock price move. Our analysis... Estimating The Intrinsic Value Of Materialise NV (NASDAQ:MTLS) Key Insights Materialise's estimated fair value is US$7.54 based on 2 Stage Free Cash Flow to Equity Current share... Materialise Second Quarter 2024 Earnings: Beats Expectations Materialise ( NASDAQ:MTLS ) Second Quarter 2024 Results Key Financial Results Revenue: €68.8m (up 6.2% from 2Q 2023... Materialise: Q2 Earnings Snapshot LEVUEN, Belgium (AP) — Materialise NV (MTLS) on Wednesday reported earnings of $4.2 million in its second quarter. On a per-share basis, the Levuen, Belgium-based company said it had profit of 7 cents. The 3D printing software and medical and industrial products company posted revenue of $73.6 million in the period. Performance Overview Trailing total returns as of 12/30/2024, which may include dividends or other distributions. Benchmark is MSCI WORLD Return MTLS MSCI WORLD YTD +7.61% +17.73% 1-Year +7.61% +17.73% 3-Year -70.87% +15.01%